Ergomed

Highly Engaged Employees

Ergomed, founded in 1997, is a specialized clinical research organization (CRO) providing comprehensive drug development and clinical trial management services. The company supports pharmaceutical, generic, and small-to-mid-sized drug development firms through a suite of specialized solutions, including pharmacovigilance, medical information services, and site support. By focusing on complex therapeutic areas such as oncology, hematology, respiratory, and neurology, Ergomed facilitates the advancement of novel treatments and orphan drugs. Their operational model emphasizes cost-efficient outsourcing, enabling clients to navigate the rigorous demands of clinical research and regulatory compliance effectively.

Operating with a workforce of 1,000-5,000 employees, Ergomed maintains a robust global footprint across 6 strategic locations. The company leverages its extensive expertise to provide end-to-end clinical development services, ensuring high-quality data management and patient safety monitoring throughout the drug lifecycle. Learn about Ergomed's global headquarters for detailed information regarding their primary operational hub in Guildford, Surrey, United Kingdom. This central facility coordinates the company's international activities, supporting a diverse portfolio of clinical projects that span multiple continents and regulatory environments.

Ergomed’s market positioning is defined by its commitment to rare disease research and the development of innovative pharmaceutical solutions. The organization integrates advanced technology with deep scientific knowledge to optimize clinical trial outcomes and accelerate time-to-market for critical therapies. Meet Ergomed's team to explore the leadership and scientific expertise driving their clinical research initiatives. With annual revenues reaching $380.4M, the company continues to expand its influence within the global life sciences sector, consistently delivering value through specialized CRO services and strategic site support.